In July, the US Food and Drug Administration (FDA) approved a new blood-based test to screen for colorectal cancer (CRC). The FDA's approval of Shield (Guardant Health) marks a notable achievement, as ...

The COVID-19 pandemic yielded important advances in testing for respiratory viruses, but it also exposed important unmet needs in screening to prevent the spread of infections in high-risk settings.

The new option will be covered by private insurance beginning in January 2027. A major update to federal women’s health preventive guidance will make it easier for women to get screened for cervical ...

Testing for high-risk human papillomaviruses every five years – even with a self-collected sample – is the “preferred screening strategy” for cervical cancer starting at age 30, according to a new ...

Mailed HPV self-collection kits more than doubled cervical cancer screening participation compared to a telephone reminder Screening rates increased to 41.1% and 46.6% with self-collection kits versus ...